Inactive Instrument

All News Propanc Biopharma Inc Other OTC

Equities

US74346N1072

All News

Unlock all the news: Be the first to know and act before the market!

Propanc Biopharma Receives Certificate of Grant for Proenzymes Composition Patent from Japanese Patent Office	06-26	AQ
Propanc Biopharma, Inc. Receives Certificate of Grant for "Proenzymes Composition" Patent from Japanese Patent Office	06-25	CI
Propanc Biopharma, Inc. announced that it has received $0.03375 million in funding	06-19	CI
Propanc Biopharma, Inc. announced that it has received $0.041 million in funding from 1800 Diagonal Lending, LLC	06-16	CI
Propanc Biopharma, Inc. Enters into and Closed a Loan Agreement with an Investor	06-13	CI
Propanc Biopharma, Inc. announced that it has received $0.041 million in funding from 1800 Diagonal Lending, LLC	05-30	CI
Propanc Biopharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	05-15	CI
Propanc Biopharma : Material Agreement - Form 8-K	04-22	PU
Propanc Biopharma Receives Certificate of Grant for Composition of Proenzymes for Cancer Treatment Patent from European Patent Office	04-17	AQ
Propanc Biopharma, Inc. Receives Certificate of Grant for ?Composition of Proenzymes for Cancer Treatment? Patent from European Patent Office	04-16	CI
Propanc Biopharma, Inc. announced that it has received $0.025 million in funding from GS Capital Partners LLC	04-15	CI
Propanc Biopharma's CEO Shares Views on Revolutionizing Cancer Treatment, an inside Look at Drug Development and Strategic Financing	04-09	AQ
Propanc Biopharma : Material Agreement - Form 8-K	03-11	PU
Propanc Biopharma, Inc. announced that it has received $0.046875 million in funding	02-29	CI
Propanc Biopharma to Host Corporate Update Call Highlighting Recent Progress and Positive Results from Compassionate Use Study	02-23	AQ
Propanc Biopharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	02-20	CI
Propanc Biopharma Receives Certificate of Grant for PRP Foundation Patent from Canadian Intellectual Property Office	01-16	CI
Propanc Biopharma's Joint Research Partner Pushing Boundaries to Circumvent Chemotherapy Resistance Using PRP	12-14	AQ
Propanc Biopharma, Inc. announced that it has received $0.135 million in funding	12-10	CI
Propanc Biopharma, Inc. announced that it has received $0.045 million in funding	12-03	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Propanc Biopharma Inc Other OTC

Equities

US74346N1072

All News

Filters